Literature DB >> 26650802

Transcranial sonography in movement disorders: an interesting tool for diagnostic perspectives.

E Sanzaro1, F Iemolo2,3.   

Abstract

Transcranial sonography has become an important tool for the diagnosis of various movement disorders. In most patients with idiopathic Parkinson disease, a markedly hyperechogenic substantia nigra (SN) was detected on at least one side. We have highlighted the sonographic features that might help the differential diagnosis of PD and other movement disorders. Our investigation involved 30 patients (age 45-85 years) with idiopathic Parkinson disease, 2 multiple system atrophy, 3 progressive supranuclear palsy and 2 patients with restless legs syndrome. In accordance with several previous studies, we detected hyperechogenicity of the SN by TCS in 90% of patients with idiopathic Parkinson disease. Subjects with a marked severity disease had a larger extent of the hyperechogenic SN signal. All progressive supranuclear palsy patients had an enlarged third ventricle and, in two cases, we observed the presence of hyperechoic areas in the lentiform nucleus. This last ultrasonographic feature was also seen in our patients with multiple system atrophy. TCS abnormalities of the SN, midbrain raphe and basal ganglia are characteristics of several movement and affective disorders. These features are less easily detected by other techniques, such as CT and MRI, which enable the exclusion of structural lesions, such as tumours and multi-infarct disease, because the physical principle differs from other imaging methods.

Entities:  

Keywords:  Parkinsonisms; Parkinson’s disease; Transcranial sonography; Ultrasound

Mesh:

Year:  2015        PMID: 26650802     DOI: 10.1007/s10072-015-2424-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  10 in total

1.  A new assessment tool for Parkinson disease: the nigral lesion load obtained by transcranial sonography.

Authors:  Enzo Sanzaro; Francesco Iemolo; Giovanni Duro; Giovanni Malferrari
Journal:  J Ultrasound Med       Date:  2014-09       Impact factor: 2.153

2.  Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound.

Authors:  S Behnke; D Berg; M Naumann; G Becker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

3.  Transcranial sonography in the evaluation of Parkinson disease.

Authors:  Goran Kolevski; Igor Petrov; Vera Petrova
Journal:  J Ultrasound Med       Date:  2007-04       Impact factor: 2.153

4.  In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.

Authors:  Luigi Zecca; Daniela Berg; Thomas Arzberger; Petra Ruprecht; Wolf D Rausch; Massimo Musicco; Davide Tampellini; Peter Riederer; Manfred Gerlach; Georg Becker
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

5.  Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.

Authors:  W R Wayne Martin; Marguerite Wieler; Myrlene Gee
Journal:  Neurology       Date:  2008-01-02       Impact factor: 9.910

6.  Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease.

Authors:  Jörg Spiegel; Dirk Hellwig; Marc-Oliver Möllers; Stefanie Behnke; Wolfgang Jost; Klaus Fassbender; Samuel Samnick; Ulrich Dillmann; Georg Becker; Carl-Martin Kirsch
Journal:  Brain       Date:  2006-03-02       Impact factor: 13.501

Review 7.  Transcranial sonography in movement disorders.

Authors:  Daniela Berg; Jana Godau; Uwe Walter
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

8.  The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.

Authors:  Alexandra Gaenslen; Barbara Unmuth; Jana Godau; Inga Liepelt; Adriana Di Santo; Katherine Johanna Schweitzer; Thomas Gasser; Hans-Jürgen Machulla; Matthias Reimold; Kenneth Marek; Daniela Berg
Journal:  Lancet Neurol       Date:  2008-04-03       Impact factor: 44.182

Review 9.  Biomarkers and Parkinson's disease.

Authors:  A W Michell; S J G Lewis; T Foltynie; R A Barker
Journal:  Brain       Date:  2004-06-23       Impact factor: 13.501

10.  Recent imaging advances in neurology.

Authors:  Lorenzo Rocchi; Flavia Niccolini; Marios Politis
Journal:  J Neurol       Date:  2015-03-26       Impact factor: 4.849

  10 in total
  5 in total

1.  Transcranial sonography image characteristics in different Parkinson's disease subtypes.

Authors:  Ai Yan Sheng; Ying Chun Zhang; Yu Jing Sheng; Cai Shan Wang; Ying Zhang; Hua Hu; Wei Feng Luo; CHun-Feng LIu
Journal:  Neurol Sci       Date:  2017-07-19       Impact factor: 3.307

2.  The predictive power of transcranial sonography in movement disorders: a longitudinal cohort study.

Authors:  Daniela Monaco; Daniela Berg; Astrid Thomas; Vincenzo Di Stefano; Filomena Barbone; Michela Vitale; Camilla Ferrante; Laura Bonanni; Marta Di Nicola; Tonia Garzarella; Luciano Paolo Marchionno; Giovanni Malferrari; Rocco Di Mascio; Marco Onofrj; Raffaella Franciotti
Journal:  Neurol Sci       Date:  2018-08-07       Impact factor: 3.307

Review 3.  Transcranial Sonography of the Substantia Nigra for the Differential Diagnosis of Parkinson's Disease and Other Movement Disorders: A Meta-Analysis.

Authors:  Yan-Liang Mei; Jing Yang; Zheng-Rong Wu; Ying Yang; Yu-Ming Xu
Journal:  Parkinsons Dis       Date:  2021-04-30

4.  3D shape analysis of the brain's third ventricle using a midplane encoded symmetric template model.

Authors:  Jaeil Kim; Maria del C Valdés Hernández; Natalie A Royle; Susana Muñoz Maniega; Benjamin S Aribisala; Alan J Gow; Mark E Bastin; Ian J Deary; Joanna M Wardlaw; Jinah Park
Journal:  Comput Methods Programs Biomed       Date:  2016-02-28       Impact factor: 5.428

5.  Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology.

Authors:  Daniel Richter; Aristeidis H Katsanos; Christoph Schroeder; Georgios Tsivgoulis; George P Paraskevas; Thomas Müller; Andrei V Alexandrov; Ralf Gold; Lars Tönges; Christos Krogias
Journal:  Cells       Date:  2019-12-18       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.